Tony Shuker

Nessuna posizione attualmente

Health Technology

Consumer Services

Technology Services

Profilo

Tony Shuker is President and Chief Executive Officer of MetaStatix, Inc. He is President of NuTec Life Sciences and EmTech Bioscience.
Most recently, Dr. Shuker worked for Somatocor Pharmaceuticals and founded Prism Therapeutics.
Formerly, he was a Senior Scientist for Eli Lilly and Co. Dr. Shuker is a Member of the Board of the Georgia Biomedical Partnership, the Atlanta Biotechnology Network and the Metro Atlanta Biotechnology Task Force.
He was a SERC/NATO Research Fellow at Stanford University.
Dr. Shuker received a degree from the University of Bath and a PhD from the University of Nottingham.

Precedenti posizioni note di Tony Shuker

Società	Posizione	Fine
Metastatix, Inc. Metastatix, Inc. Pharmaceuticals: MajorHealth Technology Metastatix, Inc. develops small molecule drugs to treat life-threatening diseases including cancer, HIV infection, and macular degeneration. It has developed a series of novel oral small-molecule CXCR4 inhibitors that have unprecedented biological activity in preclinical models. The company was founded in 2005 and is located in Tucker, GA.	Presidente	22/06/2009
Emtech, Inc. Emtech, Inc. Medical SpecialtiesHealth Technology Emtech, Inc. manufactures injection molding, computer numerical control machining, and tool building services. The company is headquartered in Circle Pines, MN	Presidente	-
NuTec Sciences, Inc. NuTec Sciences, Inc. Packaged SoftwareTechnology Services NuTec Sciences, Inc. is a company based in Alpharetta, GA.	Presidente	-

Vedi nel dettaglio l'esperienza di Tony Shuker

Formazione di Tony Shuker

University of Bath	Undergraduate Degree
The University of Nottingham	Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private